Coagulation, Protease-Activated Receptors, and Diabetic Kidney Disease: Lessons from eNOS-Deficient Mice

• Published in: The Tohoku Journal of Experimental Medicine Vol. 255; no. 1; pp. 1 - 8
• Main Authors: Oe, Yuji, Miyazaki, Mariko, Takahashi, Nobuyuki
• Format: Journal Article
• Language: English
• Published: Tohoku University Medical Press 2021
• Subjects: diabetic glomerulosclerosis; factor Xa; inflammation; tissue factor
• ISSN: 0040-8727; 1349-3329; 1349-3329
• DOI: 10.1620/tjem.255.1

Endothelial nitric oxide synthase (eNOS) dysfunction is known to exacerbate the progression and prognosis of diabetic kidney disease (DKD). One of the mechanisms through which this is achieved is that low eNOS levels are associated with hypercoagulability, which promotes kidney injury. In the extrinsic coagulation cascade, the tissue factor (factor III) and downstream coagulation factors, such as active factor X (FXa), exacerbate inflammation through activation of the protease-activated receptors (PARs). Recently, it has been shown that the lack of or reduced eNOS expression in diabetic mice, as a model of advanced DKD, increases renal tissue factor levels and PAR1 and 2 expression in their kidneys. Furthermore, pharmaceutical inhibition or genetic deletion of coagulation factors or PARs ameliorated inflammation in DKD in mice lacking eNOS. In this review, we summarize the relationship between eNOS, coagulation, and PARs and propose a novel therapeutic option for the management of patients with DKD.